The Europe dry eye products market is expected to grow from US$ 1,993.06 million in 2021 to US$ 2,781.57 million by 2028. It is estimated to grow at a CAGR of 4.9% from 2021 to 2028.

Growing Geriatric Population

The incidence of dry eye is commonly seen in people aged 65 and above. The geriatric population is increasing rapidly across the region. The older population is becoming a significant social transformation such as depending on the other for financial needs and wellness on the younger people in the present century. Older people are significantly contributing to the development of the medical sector as it helps by offering various innovative techniques to treat older people. Various healthcare companies design their products by focusing on the geriatric population. As the degeneration process among older people is much faster, they are highly prevalent to dry eye conditions. Therefore, the high prevalence of dry eye among the older population is likely to encourage manufacturers to introduce new dry eye products in the market, which, in turn, contributes to the market’s growth. The development in the healthcare industry has offered various hi-tech healthcare facilities, allowing increased life expectancy. Countries across the region are adopting new techniques to treat older people safely and effectively. Therefore, the increased quality of life is decreasing the death rates, and the older population is growing significantly all over the region. The growing geriatric population is expected to increase the demand for dry eye products such as artificial tears. These are available over-the-counter (OTC) and can be used as a supplement to natural tears. So, growing geriatric population is expected to drive the market growth.

Market Overview

The Europe dry eye products market includes the consolidated markets for Germany, France, the UK, Italy, Spain, and the Rest of Europe. Germany held the largest share of the Europe dry eye products market in 2021. Germany is among the countries that have high numbers of patients who are living with eye disorders. Also, the growing number of older people in the country is anticipated to increase the incidence of dry eye condition. Another leading driver for dry eye market is glaucoma. The incidence of glaucoma in Germany is increasing. For instance, the article “The Prevalence of Glaucoma in Young People” published in 2017 states that the prevalence of juvenile glaucoma was around 0.01%, which was based on history, based study. The prevalence of glaucoma was higher in the 18–40 age group, nearly 0.16%. The prevalence of glaucoma was much higher in adults, which accounted for approximately 1.98%. In addition, the country is experiencing market consolidation in the dry eye products market. For instance, in October 2015, SAARBRÜCKEN, Germany & HEIDELBERG, Germany signed an agreement with Novaliq to launch EvoTears in Europe. Thus, such strategic developments are likely to influence market growth during the forecast period.

Europe Dry Eye Products Market Revenue and Forecast to 2028 (US$ Million)

Europe Dry Eye Products Market Segmentation

The Europe dry eye products market is segmented based on product, type, and country.

Based on product, the Europe dry eye products market is segmented into artificial tears, antibiotic drops, hormone drops, and others. The artificial tears segment held the largest market share in 2021. The artificial tears segment is further bifurcated into OTC artificial tears and prescription artificial tears.

Based on type, the Europe dry eye products market is bifurcated into OTC drugs and prescription drugs. The OTC drugs segment held a larger market share in 2021.

Based on country, the Europe dry eye products market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the market in 2021.

AbbVie Inc; Bausch Health Companies Inc.; Johnson and Johnson Services, Inc.; Novartis AG; OASIS Medical; OCuSOFT Inc.; Prestige Consumer Healthcare Inc.; ROHTO Pharmaceutical Co, Ltd.; Santen Pharmaceutical Co., Ltd.; and URSAPHARM Arzneimittel GmbH are among the leading companies operating in the Europe dry eye products market.

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Dry Eye Products Market – By Product
1.3.2 Europe Dry Eye Products Market – By Type
1.3.3 Europe Dry Eye Products Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Dry Eye Products Market – Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
4.3 Expert Opinion
5. Europe Dry Eye Products Market – Key Market Dynamics
5.1 Market Driver
5.1.1 Rising Incidences of Dry Eye
5.1.2 Growing Older Population
5.2 Market Restraints
5.2.1 Side Effects Caused Due to Eye Drops
5.3 Market Opportunities
5.3.1 Stem Cell Therapy
5.4 Future Trends
5.4.1 Ongoing Research and Growing Pipeline for Dry Eye Products
5.5 Impact Analysis of Drivers and Restraints
6. Dry Eye Products Market – Europe Analysis
6.1 Europe Dry Eye Products Market Revenue Forecast and Analysis
7. Europe Dry Eye Products Market Analysis – By Product
7.1 Overview
7.2 Europe Dry Eye Products Market Revenue Share, by Product (2021 and 2028)
7.3 Artificial Tears
7.3.1 Overview
7.3.2 Artificial Tears: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 Over-The-Counter (OTC) Artificial Tears
7.3.3.1 Overview
7.3.3.2 OTC Artificial Tears Market Revenue and Forecast to 2028 (US$ Million)
7.3.4 Prescription Artificial Tears
7.3.4.1 Overview
7.3.4.2 Prescription Artificial Tears Market Revenue and Forecast to 2028 (US$ Million)
7.4 Antibiotics Drops
7.4.1 Overview
7.4.2 Antibiotic Drops: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Hormone Drops
7.5.1 Overview
7.5.2 Hormone Drops: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
8. Europe Dry Eye Products Market Analysis – By Type
8.1 Overview
8.2 Europe Dry Eye Products Market, by Type, 2021 and 2028 (%)
8.3 OTC Drugs
8.3.1 Overview
8.3.2 OTC Drugs: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Prescription Drugs
8.4.1 Overview
8.4.2 Prescription Drugs: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
9. Europe Dry Eye Products Market – Country Analysis
9.1 Overview
9.1.1 Europe: Dry Eye Products Market, by Country, 2021 & 2028 (%)
9.1.2 Germany: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
9.1.2.1 Overview
9.1.2.2 Germany: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
9.1.2.3 Germany: Dry Eye Products Market, by Product – Revenue and Forecast to 2028 (US$ Million)
9.1.2.3.1 Germany: Dry Eye Products Market, by Artificial Tears, 2019–2028 (US$ Million)
9.1.2.4 Germany: Dry Eye Products Market, by Type – Revenue and Forecast to 2028 (US$ Million)
9.1.3 France: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
9.1.3.1 Overview
9.1.3.2 France: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
9.1.3.3 France: Dry Eye Products Market, by Product– Revenue and Forecast to 2028 (US$ Million)
9.1.3.3.1 France: Dry Eye Products Market, by Artificial Tears, 2019–2028 (US$ Million)
9.1.3.4 France: Dry Eye Products Market, Type – Revenue and Forecast to 2028 (US$ Million)
9.1.4 UK: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
9.1.4.1 Overview
9.1.4.2 UK: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
9.1.4.3 UK: Dry Eye Products Market, by Product – Revenue and Forecast to 2028 (US$ Million)
9.1.4.3.1 UK: Dry Eye Products Market, by Artificial Tears, 2019–2028 (US$ Million)
9.1.4.4 UK: Dry Eye Products Market, by Type – Revenue and Forecast to 2028 (US$ Million)
9.1.5 Italy: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
9.1.5.1 Overview
9.1.5.2 Italy: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
9.1.5.3 Italy: Dry Eye Products Market, by Product – Revenue and Forecast to 2028 (US$ Million)
9.1.5.3.1 Italy: Dry Eye Products Market, by Artificial Tears, 2019–2028 (US$ Million)
9.1.5.4 Italy: Dry Eye Products Market, by Type – Revenue and Forecast to 2028 (US$ Million)
9.1.6 Spain: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
9.1.6.1 Overview
9.1.6.2 Spain: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
9.1.6.3 Spain: Dry Eye Products Market, by Product – Revenue and Forecast to 2028 (US$ Million)
9.1.6.3.1 Spain: Dry Eye Products Market, by Artificial Tears, 2019–2028 (US$ Million)
9.1.6.4 Spain: Dry Eye Products Market, by Type – Revenue and Forecast to 2028 (US$ Million)
9.1.7 Rest of Europe: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
9.1.7.1 Overview
9.1.7.2 Rest of Europe: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
9.1.7.3 Rest of Europe: Dry Eye Products Market, by Product – Revenue and Forecast to 2028 (US$ Million)
9.1.7.3.1 Rest of Europe: Dry Eye Products Market, by Artificial Tears, 2019–2028 (US$ Million)
9.1.7.4 Rest of Europe: Dry Eye Products Market, by Type – Revenue and Forecast to 2028 (US$ Million)
10. Industry Landscape
10.1 Overview
10.2 Organic Developments
10.2.1 Overview
10.3 Inorganic Developments
10.3.1 Overview
11. Company Profiles
11.1 Novartis AG
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Santen Pharmaceutical Co., Ltd.
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Johnson and Johnson Services, Inc.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 OASIS Medical
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 URSAPHARM Arzneimittel GmbH
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 ROHTO Pharmaceutical Co, Ltd.
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 OCuSOFT Inc.
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Bausch Health Companies Inc.
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 AbbVie Inc.
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Prestige Consumer Healthcare Inc.
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. Appendix
12.1 Glossary of Terms

LIST OF TABLES

Table 1. Europe Dry Eye Products Market –Revenue and Forecast to 2028 (US$ Million)
Table 2. Germany: Dry Eye Products Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 3. Germany Dry Eye Products Market, by Artificial Tears – Revenue and Forecast to 2028 (US$ Million)
Table 4. Germany: Dry Eye Products Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 5. France: Dry Eye Products Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 6. France Dry Eye Products Market, by Artificial Tears – Revenue and Forecast to 2028 (US$ Million)
Table 7. France: Dry Eye Products Market, Type – Revenue and Forecast to 2028 (US$ Million)
Table 8. UK: Dry Eye Products Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 9. UK Dry Eye Products Market, by Artificial Tears – Revenue and Forecast to 2028 (US$ Million)
Table 10. UK: Dry Eye Products Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 11. Italy: Dry Eye Products Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 12. Italy Dry Eye Products Market, by Artificial Tears – Revenue and Forecast to 2028 (US$ Million)
Table 13. Italy: Dry Eye Products Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 14. Spain: Dry Eye Products Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 15. Spain Dry Eye Products Market, by Artificial Tears – Revenue and Forecast to 2028 (US$ Million)
Table 16. Spain: Dry Eye Products Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 17. Rest of Europe: Dry Eye Products Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 18. Rest of Europe Dry Eye Products Market, by Artificial Tears – Revenue and Forecast to 2028 (US$ Million)
Table 19. Rest of Europe: Dry Eye Products Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 20. Organic Developments Done By Companies
Table 21. Inorganic Developments Done By Companies
Table 22. Glossary of Terms

LIST OF FIGURES

Figure 1. Europe Dry Eye Products Market Segmentation
Figure 2. Europe Dry Eye Products Market – By Country
Figure 3. Europe Dry Eye Products Market Overview
Figure 4. Europe Dry Eye Products Market, By Product
Figure 5. Europe Dry Eye Products Market, By Country
Figure 7. Europe PEST Analysis
Figure 8. Expert Opinion
Figure 9. Europe Dry Eye Products Market Impact Analysis of Drivers and Restraint
Figure 10. Europe Dry Eye Products Market – Revenue Forecast And Analysis
Figure 11. Europe Dry Eye Products Market Revenue Share, by Product (2021 and 2028)
Figure 12. Europe Artificial Tears: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Europe OTC Artificial Tears Market Revenue and Forecast to 2028 (US$ Million)
Figure 14. Europe Prescription Artificial Tears Market Revenue and Forecast to 2028 (US$ Million)
Figure 15. Europe Antibiotic Drops: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Europe Hormone Drops: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Europe Others: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Europe Dry Eye Products Market, by Type, 2021 and 2028 (%)
Figure 19. Europe OTC Drugs: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Europe Prescription Drugs: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Europe: Dry Eye Products Market, by Key Country – Revenue (2021) (US$ Million)
Figure 22. Europe: Dry Eye Products Market, by Country, 2021 & 2028 (%)
Figure 23. Germany: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. France: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. UK: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Italy: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Spain: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Rest of Europe: Dry Eye Products Market – Revenue and Forecast to 2028 (US$ Million)

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe dry eye products market.
● Highlights key business priorities in order to assist companies to realign their business strategies
● The key findings and recommendations highlight crucial progressive industry trends in the Europe dry eye products market, thereby allowing players across the value chain to develop effective long-term strategies
● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
● Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the dry eye products market, as well as those hindering it
● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

● AbbVie Inc
● Bausch Health Companies Inc.
● Johnson and Johnson Services, Inc.
● Novartis AG
● OASIS Medical
● OCuSOFT Inc.
● Prestige Consumer Healthcare Inc.
● ROHTO Pharmaceutical Co, Ltd.
● Santen Pharmaceutical Co., Ltd.
● URSAPHARM Arzneimittel GmbH

At 4.9% CAGR, the Europe Eye Products Market is speculated to be worth US$ 2,781.57 million by 2028, says The Insight Partners

According to The Insight Partners’ research, the Europe eye products market was valued at US$ 1,993.06 million in 2021 and is expected to reach US$ 2,781.57 million by 2028, registering a CAGR of 4.9% from 2021 to 2028. Growing older population and stem cell therapy are the critical factors attributed to the market expansion.

The technologies are emerging based on stem cell therapy that can help in treating a dry eye condition. The aim is to prevent disease development, regeneration, and maintaining corneal transparency. Whereas most of the recent advances do not respond to conventional methods. Therefore, researchers prefer autologous or allogeneic serum drops, platelet-derived plasma products, and umbilical cord blood serum to study them as a treatment method. Additionally, the researchers are focusing on using cytokines and different cell sources such as mesenchymal stem cells more preferably to cure dry eye conditions. During the studies, it was found that mesenchymal cells assist in improving tear volume, tear-film stability, epithelial recovery, and the number of goblet cells. The cells help in decreasing the number of meibomian gland injuries in the conjunctiva, which is expected to be the most promising advancement for the dry eye condition treatment. The other stem cell therapy-based treatment is by using lubricin. Lubricin is a protein present in the tear film that allows lubrication in between eye surface and eyelid. The researchers are aiming to introduce proper treatment that can cure dry eye conditions completely. Thus, advancements in the healthcare industry that has allowed integration of biotechnology and pharmaceutical are likely to propel the market growth during the forecast period.

On the contrary, side effects caused due to eye drops hurdles the growth of Europe eye products market.

Based on product, the Europe dry eye products market is segmented into artificial tears, antibiotic drops, hormone drops, and others. The artificial tears segment held 48.8% market share in 2021, amassing US$ 971.62 million. It is projected to garner US$ 1,328.77 million by 2028 to expand at 4.6% CAGR during 2021–2028. The artificial tears segment is further bifurcated into OTC artificial tears and prescription artificial tears.

Based on type, the Europe dry eye products market is bifurcated into OTC drugs and prescription drugs. The OTC drugs segment held 55.1% market share in 2021, amassing US$ 1,098.02 million. It is projected to garner US$ 1,492.19 million by 2028 to expand at 4.5% CAGR during 2021–2028.

Based on country, the Europe dry eye products market has been categorized into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that Germany captured 22.2% market share in 2021. It was assessed at US$ 443.21 million in 2021 and is likely to hit US$ 658.27 million by 2028, exhibiting a CAGR of 5.8% during the forecast period.

Key players dominating the Europe dry eye products market are AbbVie Inc; Bausch Health Companies Inc.; Johnson and Johnson Services, Inc.; Novartis AG; OASIS Medical; OCuSOFT Inc.; Prestige Consumer Healthcare Inc.; ROHTO Pharmaceutical Co, Ltd.; Santen Pharmaceutical Co., Ltd.; and URSAPHARM Arzneimittel GmbH among others.

In July 2021, TheraTears was acquired by Prestige Consumer Healthcare Inc. The acquisition of TheraTears added to Prestige’s leading eye care portfolio and provide the company with new long-term growth prospects. In April 2021, OASIS Medical Inc launched its new patented cyber platform MY OASIS at SECO International 2021.